Our Team

Our Leadership

Anand Khedkar

PhD | Co-Founder | Director

Anand Khedkar

PhD | Co-Founder | Director

Ph. D from Deakin University. Expert in process development and CMC, taken multiple molecules to registration. 25+ years in biopharma across Biocon, Apobiologix, Kinexum, Stelis. Led Asia’s largest viral Vector Vaccine technology scaleup and manufacturing for Sars-Cov-2.

Monalisa Chatterji

PhD | Co-Founder | Director

Monalisa Chatterji

PhD | Co-Founder | Director

She has a Ph.D.–IISc Post Doctoral from Yale University. Expert in early discovery, taken molecules to phase I. 20+ years in R&D; (small molecules, biologics) in Astra Zeneca, Biocon, Kinexum, BMGF. Steered Covid preclinical therapeutics response at BMGF, innovator & project lead for TBA-7371(anti-infective), T1h (mAb).

Anirudh Ranganathan

PhD | Co-Founder | Director

Anirudh Ranganathan

PhD | Co-Founder | Director

Computational biologist with expertise in molecular modeling & GPCRs. He comes from academia - Science for Life Lab, SciLifeLab. Ph.D. from Stockholm University. Global assessment winning entries on GPCR modeling. Multiple F1000 recommended publications on the use of FBDD on GPCRs.

Our Advisors

Harold Lebovitz MD

MD Former HOD Duke University | Endocrinologist
Diabetes & Metabolic

Alan Cherrington

MD Ex-president ADA | HOD Vanderbilt
Diabetes & Metabolic

Scott Dax

Ph.D | Ex-CEO CerSci
Analgesia

Nigel Calcutt

Ph.D | Co-founder Winsantor UCSD
Diabetes & Neuropathy

Nigel Calcutt

Ph.D | Co-founder Winsantor UCSD
Diabetes & Neuropathy

Computational biologist with expertise in molecular modeling & GPCRs, comes from academia (Science for Life Lab, Stockholm) Ph.D. from Stockholm University. Global assessment winning entries on GPCR modeling. Multiple F1000 recommended publications on the use of FBDD on GPCRs.